Antimitochondrial Antibodies and Other Antibodies in Primary Biliary Cirrhosis: Diagnostic and Prognostic Value

Walker, 1965, Serological tests in diagnosis of primary biliary cirrhosis, Lancet, 285, 827, 10.1016/S0140-6736(65)91372-3 Bogdanos, 2003, Antimitochondrial and other autoantibodies, Clin Liver Dis, 7, 759, 10.1016/S1089-3261(03)00104-1 Kaplan, 2005, Primary biliary cirrhosis, N Engl J Med, 353, 1261, 10.1056/NEJMra043898 Berg, 1982, ATPase-associated antigen (M2): marker antigen for serological diagnosis of primary biliary cirrhosis, Lancet, 320, 1423, 10.1016/S0140-6736(82)91327-7 Lindenborn-Fotinos, 1985, Mitochondrial antibodies in primary biliary cirrhosis: species and nonspecies specific determinants of M2 antigen, Hepatology, 5, 763, 10.1002/hep.1840050510 Berg, 1992, Antimitochondrial antibodies in primary biliary cirrhosis and other disorders: definition and clinical relevance, Dig Dis, 10, 85, 10.1159/000171347 Frazer, 1985, Reactivity of anti-mitochondrial autoantibodies in primary biliary cirrhosis: definition of two novel mitochondrial polypeptide autoantigens, J Immunol, 135, 1739, 10.4049/jimmunol.135.3.1739 Gershwin, 1987, Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis, J Immunol, 138, 3525, 10.4049/jimmunol.138.10.3525 Fussey, 1988, Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis, Proc Natl Acad Sci U S A, 85, 8654, 10.1073/pnas.85.22.8654 Ishibashi, 2005, The immune response to mitochondrial autoantigens, Semin Liver Dis, 25, 337, 10.1055/s-2005-916325 Bruggraber, 2003, Autoreactivity to lipoate and a conjugated form of lipoate in primary biliary cirrhosis, Gastroenterology, 125, 1705, 10.1053/j.gastro.2003.09.034 Rizzetto, 1973, Microsomal antibodies in active chronic hepatitis and other disorders, Clin Exp Immunol, 15, 331 Homberg, 1987, Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of “autoimmune” hepatitis, Hepatology, 7, 1333, 10.1002/hep.1840070626 Gregorio, 1997, Autoimmune hepatitis in childhood: a 20-year experience, Hepatology, 25, 541, 10.1002/hep.510250308 Vergani, 2004, Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group, J Hepatol, 41, 677, 10.1016/j.jhep.2004.08.002 Worman, 2003, Antinuclear antibodies specific for primary biliary cirrhosis, Autoimmun Rev, 2, 211, 10.1016/S1568-9972(03)00013-2 Invernizzi, 2005, Antinuclear antibodies in primary biliary cirrhosis, Semin Liver Dis, 25, 298, 10.1055/s-2005-916321 Muratori, 2004, ‘True’ antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both?, Clin Exp Immunol, 135, 154, 10.1111/j.1365-2249.2004.02332.x Muratori, 2005, The Western immunoblotting pattern of anti-mitochondrial antibodies is independent of the clinical expression of primary biliary cirrhosis, Dig Liver Dis, 37, 108, 10.1016/j.dld.2004.09.019 Heseltine, 1990, Primary biliary cirrhosis. Quantitation of autoantibodies to purified mitochondrial enzymes and correlation with disease progression, Gastroenterology, 99, 1786, 10.1016/0016-5085(90)90488-M Moteki, 1996, Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies, Hepatology, 24, 97, 10.1002/hep.510240117 Miyakawa, 2001, Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens, Hepatology, 34, 243, 10.1053/jhep.2001.26514 Oertelt, 2007, A sensitive bead assay for antimitochondrial antibodies: chipping away at AMA-negative primary biliary cirrhosis, Hepatology, 45, 659, 10.1002/hep.21583 Gabeta, 2007, Diagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosis, J Clin Immunol, 27, 378, 10.1007/s10875-007-9092-0 Invernizzi, 1997, Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis, Hepatology, 25, 1090, 10.1002/hep.510250507 Zhang, 2004, Clinical evaluation of serum antimitochondrial antibody-negative primary biliary cirrhosis, Hepatobiliary Pancreat Dis Int, 3, 288 Kim, 1997, Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation, Hepatology, 26, 22, 10.1002/hep.510260103 Mitchison, 1986, Positive antimitochondrial antibody but normal alkaline phosphatase: is this primary biliary cirrhosis?, Hepatology, 6, 1279, 10.1002/hep.1840060609 Metcalf, 1996, Natural history of early primary biliary cirrhosis, Lancet, 348, 1399, 10.1016/S0140-6736(96)04410-8 Springer, 1999, Asymptomatic primary biliary cirrhosis: a study of its natural history and prognosis, Am J Gastroenterol, 94, 47, 10.1111/j.1572-0241.1999.00770.x Prince, 2002, Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years, Gastroenterology, 123, 1044, 10.1053/gast.2002.36027 Prince, 2004, Asymptomatic primary biliary cirrhosis: clinical features, prognosis, and symptom progression in a large population based cohort, Gut, 53, 865, 10.1136/gut.2003.023937 Heathcote, 2000, Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines, Hepatology, 31, 1005, 10.1053/he.2000.5984 Van Norstrand, 1997, Quantitative measurement of autoantibodies to recombinant mitochondrial antigens in patients with primary biliary cirrhosis: relationship of levels of autoantibodies to disease progression, Hepatology, 25, 6, 10.1002/hep.510250103 Klein, 1991, Antimitochondrial antibody profiles determined at early stages of primary biliary cirrhosis differentiate between a benign and a progressive course of the disease. A retrospective analysis of 76 patients over 6-18 years, J Hepatol, 12, 21, 10.1016/0168-8278(91)90903-O Klein, 1997, Antimitochondrial antibody profiles in primary biliary cirrhosis distinguish at early stages between a benign and a progressive course: a prospective study on 200 patients followed for 10 years, Liver, 17, 119, 10.1111/j.1600-0676.1997.tb00793.x Joshi, 2002, Antimitochondrial antibody profiles: are they valid prognostic indicators in primary biliary cirrhosis?, Am J Gastroenterol, 97, 999, 10.1111/j.1572-0241.2002.05620.x Masuda, 2003, Correlation between histopathological findings of the liver and IgA class antibodies to 2-oxo-acid dehydrogenase complex in primary biliary cirrhosis, Dig Dis Sci, 48, 932, 10.1023/A:1023055714208 Omagari, 2006, IgA class antibodies to 2-oxo-acid dehydrogenase complex are not predictive markers of histopathological progression in primary biliary cirrhosis, Autoimmunity, 39, 107, 10.1080/08916930600633006 Kisand, 1998, Antibodies to pyruvate dehydrogenase in primary biliary cirrhosis: correlation with histology, APMIS, 106, 884, 10.1111/j.1699-0463.1998.tb00235.x Rigopoulou, 2007, Antimitochondrial antibodies of immunoglobulin G3 subclass are associated with a more severe disease course in primary biliary cirrhosis, Liver Int, 27, 1226, 10.1111/j.1478-3231.2007.01586.x Rigopoulou, 2007, Anti-mitochondrial antibody immunofluorescent titres correlate with the number and intensity of immunoblot-detected mitochondrial bands in patients with primary biliary cirrhosis, Clin Chim Acta, 380, 118, 10.1016/j.cca.2007.01.023 Nalbandian, 1999, Is there a serological difference between men and women with primary biliary cirrhosis?, Am J Gastroenterol, 94, 2482, 10.1111/j.1572-0241.1999.01380.x Muratori, 2007, Clinical and serological profile of primary biliary cirrhosis in men, QJM, 100, 534, 10.1093/qjmed/hcm059 Doniach, 1966, Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications, Clin Exp Immunol, 1, 237 Bernstein, 1984, Diversity of autoantibodies in primary biliary cirrhosis and chronic active hepatitis, Clin Exp Immunol, 55, 553 Kurki, 1984, Profiles of antinuclear antibodies in chronic active hepatitis, primary biliary cirrhosis and alcoholic liver disease, Liver, 4, 134, 10.1111/j.1600-0676.1984.tb00918.x Muratori, 2003, Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis, Am J Gastroenterol, 98, 431, 10.1111/j.1572-0241.2003.07257.x Bernstein, 1982, Anticentromere antibody in primary biliary cirrhosis, Ann Rheum Dis, 41, 612, 10.1136/ard.41.6.612 Parveen, 1995, High prevalence of antibodies to recombinant CENP-B in primary biliary cirrhosis: nuclear immunofluorescence patterns and ELISA reactivities, J Gastroenterol Hepatol, 10, 438, 10.1111/j.1440-1746.1995.tb01597.x Szostecki, 1990, Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis, J Immunol, 145, 4338, 10.4049/jimmunol.145.12.4338 Szostecki, 1992, Autoantibodies to the nuclear Sp100 protein in primary biliary cirrhosis and associated diseases: epitope specificity and immunoglobulin class distribution, Scand J Immunol, 36, 555, 10.1111/j.1365-3083.1992.tb03224.x Sternsdorf, 1995, Two nuclear dot-associated proteins, PML and Sp100, are often co-autoimmunogenic in patients with primary biliary cirrhosis, Scand J Immunol, 42, 257, 10.1111/j.1365-3083.1995.tb03652.x Szostecki, 1997, Autoantibodies against “nuclear dots” in primary biliary cirrhosis, Semin Liver Dis, 17, 71, 10.1055/s-2007-1007184 Lozano, 1988, Autoantibodies against nuclear envelope-associated proteins in primary biliary cirrhosis, Hepatology, 8, 930, 10.1002/hep.1840080438 Wesierska-Gadek, 1995, Autoantibodies from patients with primary biliary cirrhosis preferentially react with the amino-terminal domain of nuclear pore complex glycoprotein gp210, J Exp Med, 182, 1159, 10.1084/jem.182.4.1159 Wesierska-Gadek, 1996, Autoantibodies against nucleoporin p62 constitute a novel marker of primary biliary cirrhosis, Gastroenterology, 110, 840, 10.1053/gast.1996.v110.pm8608894 Ye, 1994, Primary structure analysis and lamin B and DNA binding of human LBR, an integral protein of the nuclear envelope inner membrane, J Biol Chem, 269, 11306, 10.1016/S0021-9258(19)78126-5 Courvalin, 1990, Identification and characterization of autoantibodies against the nuclear envelope lamin B receptor from patients with primary biliary cirrhosis, J Exp Med, 172, 961, 10.1084/jem.172.3.961 Rigopoulou, 2005, Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis, Gut, 54, 528, 10.1136/gut.2003.036558 Tsiakalou, 2006, Optimized detection of circulating anti-nuclear envelope autoantibodies by immunofluorescence, BMC Immunol, 7, 20, 10.1186/1471-2172-7-20 Nickowitz, 1994, Autoantibodies against integral membrane proteins of the nuclear envelope in patients with primary biliary cirrhosis, Gastroenterology, 106, 193, 10.1016/S0016-5085(94)95333-3 Invernizzi, 2001, Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis, J Hepatol, 34, 366, 10.1016/S0168-8278(00)00040-4 Muratori, 2002, Anti-multiple nuclear dots (anti-MND) and anti-SP100 antibodies in hepatic and rheumatological disorders, Clin Exp Immunol, 127, 172, 10.1046/j.1365-2249.2002.01719.x Vergani, 2003, Positive markers in AMA-negative PBC, Am J Gastroenterol, 98, 241, 10.1111/j.1572-0241.2003.07270.x Granito, 2006, Antinuclear antibodies giving the ‘multiple nuclear dots’ or the ‘rim-like/membranous’ patterns: diagnostic accuracy for primary biliary cirrhosis, Aliment Pharmacol Ther, 24, 1575, 10.1111/j.1365-2036.2006.03172.x Dorner, 1994, Serologic characteristics in primary biliary cirrhosis associated with sicca syndrome, Scand J Gastroenterol, 29, 655, 10.3109/00365529409092488 Akiyama, 2000, Clinical, serological and genetic study in patients with CREST syndrome, Intern Med, 39, 451, 10.2169/internalmedicine.39.451 Rigamonti, 2006, Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis, Gut, 55, 388, 10.1136/gut.2005.075002 Shoji, 1992, Anti-centromere antibody and CREST syndrome in patients with primary biliary cirrhosis, Intern Med, 31, 1348, 10.2169/internalmedicine.31.1348 Granito, 2007, Antibodies to SS-A/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis, Aliment Pharmacol Ther, 26, 831, 10.1111/j.1365-2036.2007.03433.x Itoh, 1998, Autoantibodies against a 210 kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis, J Gastroenterol Hepatol, 13, 257, 10.1111/j.1440-1746.1998.01553.x Miyachi, 2003, Profile and clinical significance of anti-nuclear envelope antibodies found in patients with primary biliary cirrhosis: a multicenter study, J Autoimmun, 20, 247, 10.1016/S0896-8411(03)00033-7 Nakamura, 2007, Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis, Hepatology, 45, 118, 10.1002/hep.21472 Janka, 2005, Small ubiquitin-related modifiers: a novel and independent class of autoantigens in primary biliary cirrhosis, Hepatology, 41, 609, 10.1002/hep.20619 Ou, 2004, The nuclear pore complex protein Tpr is a common autoantigen in sera that demonstrate nuclear envelope staining by indirect immunofluorescence, Clin Exp Immunol, 136, 379, 10.1111/j.1365-2249.2004.02432.x Fida, 2002, Autoantibodies to the transcriptional factor SOX13 in primary biliary cirrhosis compared with other diseases, J Autoimmun, 19, 251, 10.1006/jaut.2002.0622 Konstantinov, 1995, Integral membrane proteins associated with the nuclear lamina are novel autoimmune antigens of the nuclear envelope, Clin Immunol Immunopathol, 74, 89, 10.1006/clin.1995.1013 Mattalia, 1997, Persistence of autoantibodies against recombinant mitochondrial and nuclear pore proteins after orthotopic liver transplantation for primary biliary cirrhosis, J Autoimmun, 10, 491, 10.1006/jaut.1997.0156 Luettig, 1998, The antinuclear autoantibodies Sp100 and gp210 persist after orthotopic liver transplantation in patients with primary biliary cirrhosis, J Hepatol, 28, 824, 10.1016/S0168-8278(98)80233-X Dubel, 1998, Persistence of gp210 and multiple nuclear dots antibodies does not correlate with recurrence of primary biliary cirrhosis 6 years after liver transplantation, J Hepatol, 28, 169, 10.1016/S0168-8278(98)80220-1 Kenny, 1986, Frequency and significance of antimitochondrial antibodies in severe chronic active hepatitis, Dig Dis Sci, 31, 705, 10.1007/BF01296447 Czaja, 1998, Frequency and nature of the variant syndromes of autoimmune liver disease, Hepatology, 28, 360, 10.1002/hep.510280210 Chazouilleres, 1998, Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy, Hepatology, 28, 296, 10.1002/hep.510280203 Lohse, 1999, Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals, Hepatology, 29, 1078, 10.1002/hep.510290409 Heathcote, 2001, Primary biliary cirrhosis with features of autoimmune hepatitis, Curr Gastroenterol Rep, 3, 60, 10.1007/s11894-001-0042-3 Muratori, 2002, The hepatitic/cholestatic “overlap” syndrome: an Italian experience, Autoimmunity, 35, 565, 10.1080/0891693021000064272 Alvarez, 1999, International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis, J Hepatol, 31, 929, 10.1016/S0168-8278(99)80297-9 Czaja, 1997, Antibodies to single-stranded and double-stranded DNA in antinuclear antibody-positive type 1-autoimmune hepatitis, Hepatology, 26, 567, 10.1002/hep.510260306 Siegert, 1992, Antimitochondrial antibodies in patients with chronic graft-versus-host disease, Bone Marrow Transplant, 10, 221 Quaranta, 1999, Autoantibodies in human chronic graft-versus-host disease after hematopoietic cell transplantation, Clin Immunol, 91, 106, 10.1006/clim.1998.4666 Patriarca, 2006, The development of autoantibodies after allogeneic stem cell transplantation is related with chronic graft-vs-host disease and immune recovery, Exp Hematol, 34, 389, 10.1016/j.exphem.2005.12.011 Bellucci, 2007, Differential epitope mapping of antibodies to PDC-E2 in patients with hematologic malignancies after allogeneic hematopoietic stem cell transplantation and primary biliary cirrhosis, Blood, 109, 2001, 10.1182/blood-2006-06-030304 Leung, 2007, Antimitochondrial antibodies in acute liver failure: implications for primary biliary cirrhosis, Hepatology, 46, 1436, 10.1002/hep.21828 Bernal, 2007, The significance of autoantibodies and immunoglobulins in acute liver failure: a cohort study, J Hepatol, 47, 664, 10.1016/j.jhep.2007.05.011